UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005-10, Vol.11 (5), p.234-238

2005

Volltextzugriff (PDF)

Simultaneous targeting of CD14 and factor XIa by a fusion protein consisting of an anti-CD14 antibody and the modified second domain of bikunin improves survival in rabbit sepsis models

European journal of pharmacology, 2017-05, Vol.802, p.60-68

2017

Volltextzugriff (PDF)

Nrf2 deficiency leads to behavioral, neurochemical and transcriptional changes in mice

Genes to cells : devoted to molecular & cellular mechanisms, 2013-10, Vol.18 (10), p.899-908

2013

Volltextzugriff (PDF)

Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice

PloS one, 2014-11, Vol.9 (11), p.e112027-e112027

2014

Volltextzugriff (PDF)

Effects of Aryl Hydrocarbon Receptor Signaling on the Modulation of Th1/Th2 Balance

Journal of Immunology, 2005-12, Vol.175 (11), p.7348-7356

2005

Volltextzugriff (PDF)

Properties of soluble glycoprotein VI, a potential platelet activation biomarker

Platelets (Edinburgh), 2015-11, Vol.26 (8), p.745-750

2015

Volltextzugriff (PDF)

Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice

European journal of pharmacology, 2007-08, Vol.569 (3), p.237-243

2007

Volltextzugriff (PDF)

Anti-human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection

European journal of pharmacology, 2017-07, Vol.806, p.18-24

2017

Volltextzugriff (PDF)

Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients

Clinical chemistry and laboratory medicine, 2011-05, Vol.49 (5), p.937-939

2011

Volltextzugriff (PDF)

The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice

European journal of pharmacology, 2017-05, Vol.802, p.76-84

2017

Volltextzugriff (PDF)

A porcine islet-encapsulation device that enables long-term discordant xenotransplantation in immunocompetent diabetic mice

Cell reports methods, 2023-01, Vol.3 (1), p.100370-100370, Article 100370

2023

Volltextzugriff (PDF)

Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 2A inhibitor, PDM-631

European journal of pharmacology, 2017-09, Vol.811, p.110-116

2017

Volltextzugriff (PDF)

Establishment of immunoassay for platelet-derived soluble glycoprotein VI, a novel platelet marker

Journal of immunological methods, 2015-03, Vol.418, p.52-60

2015

Volltextzugriff (PDF)

(1) Immunopharmacological Characterization of Potent, Selective and Orally Available RORγt Inhibitors for Treatment of Autoimmune Diseases

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB98-AB98

2015

Volltextzugriff (PDF)

(1) Immunopharmacological Characterization of Potent, Selective and Orally Available ROR[gamma]t Inhibitors for Treatment of Autoimmune Diseases

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB98

2015

Volltextzugriff (PDF)

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex

The Journal of clinical investigation, 2008-05, Vol.118 (5), p.1785-1795

2008

Volltextzugriff (PDF)

Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (11), p.2622-2628

2017

Volltextzugriff (PDF)

An orally active Th1/Th2 balance modulator, M50367, suppresses Th2 differentiation of naı̈ve Th cell in vitro

Cellular immunology, 2003-07, Vol.224 (1), p.29-37

2003

Volltextzugriff (PDF)

Protection of mice from LPS-induced shock by CD14 antisense oligonucleotide

Acta medica Okayama, 2001-04, Vol.55 (2), p.105-115

2001

Volltextzugriff (PDF)

Characterization of a novel variant of the second domain of bikunin with increased leukocyte elastase inhibitory activity

Journal of biophysical chemistry, 2012, Vol.3 (2), p.132-141

2012

Volltextzugriff (PDF)

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor [gamma]-chain complex

The Journal of clinical investigation, 2008-05, Vol.118 (5), p.1785

2008

Volltextzugriff (PDF)

The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models

Critical care (London, England), 2007, Vol.11 (Suppl 4), p.P4-P4

2007

Volltextzugriff (PDF)

Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

Journal of Virology, 1996-08, Vol.70 (8), p.5203-5212

1996

Volltextzugriff (PDF)

A New CA125‐like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG‐II)

Cancer science, 1991-07, Vol.82 (7), p.854-861

1991

Volltextzugriff (PDF)

Characterization of Anti-Human GPVI Autoantibodies Mediating Persistent Target Immnunodepletion over a 15-Year Period

Blood, 2005-11, Vol.106 (11), p.2168-2168

2005

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(33)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

Simultaneous targeting of CD14 and factor XIa by a fusion protein consisting of an anti-CD14 antibody and the modified second domain of bikunin improves survival in rabbit sepsis models

Nrf2 deficiency leads to behavioral, neurochemical and transcriptional changes in mice

Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice

Effects of Aryl Hydrocarbon Receptor Signaling on the Modulation of Th1/Th2 Balance

Properties of soluble glycoprotein VI, a potential platelet activation biomarker

Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice

Anti-human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection

Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients

The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice

A porcine islet-encapsulation device that enables long-term discordant xenotransplantation in immunocompetent diabetic mice

Pharmacological characterization of a novel potent, selective, and orally active phosphodiesterase 2A inhibitor, PDM-631

Establishment of immunoassay for platelet-derived soluble glycoprotein VI, a novel platelet marker

(1) Immunopharmacological Characterization of Potent, Selective and Orally Available RORγt Inhibitors for Treatment of Autoimmune Diseases

(1) Immunopharmacological Characterization of Potent, Selective and Orally Available ROR[gamma]t Inhibitors for Treatment of Autoimmune Diseases

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex

Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors

An orally active Th1/Th2 balance modulator, M50367, suppresses Th2 differentiation of naı̈ve Th cell in vitro

Protection of mice from LPS-induced shock by CD14 antisense oligonucleotide

Characterization of a novel variant of the second domain of bikunin with increased leukocyte elastase inhibitory activity

A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor [gamma]-chain complex

The modified light chain of inter-alpha inhibitor/antibody fusion protein, MR1007, improves survival in the rabbit sepsis models

Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes

A New CA125‐like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG‐II)

Characterization of Anti-Human GPVI Autoantibodies Mediating Persistent Target Immnunodepletion over a 15-Year Period

Suchergebnisse filtern